Pfizer
Business & Industry
- Pfizer and Valneva's Lyme disease vaccine candidate Marketing Authorization Application validated by European Medicines Agency
- Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI
- Sanofi Foundation opens new chapter centered on future generations
- Bristol Myers Squibb evolves and expands Standing in the Gaap to advance more equitable care in multiple myeloma
- Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
Research & Development
- AI designs a novel E. coli killer
- GLP-1 drug linked to heart benefits for high-risk patients
- FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber
- Targeting MDA-9 restrains head and neck tumor growth and eliminates therapy resistance
- Engineered human neurons rebuild damaged spinal cord circuits
- Scientists unveil more than 600 new tissue models of human cancer
- CS18: a new drug that can potentially overcome cancer drug resistance
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA expands artificial intelligence capabilities with agentic AI deployment
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B
- FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- FDA approves first nasal spray for treatment of anaphylaxis